ADP
61
-3
KR
40
3
AME
54
-8
NI
58
-5
ETR
66
-9
O
30
-5
CI
52
7
SWK
64
3
XEL
58
-4
FITB
52
-4
AEE
50
-3
PRU
51
-3
CMA
52
-3
ABT
62
9
MA
58
3
MO
57
-3
NRG
59
-10
MSI
60
2
JNPR
59
3
F
35
-4
ADP
61
-3
KR
40
3
AME
54
-8
NI
58
-5
ETR
66
-9
O
30
-5
CI
52
7
SWK
64
3
XEL
58
-4
FITB
52
-4
AEE
50
-3
PRU
51
-3
CMA
52
-3
ABT
62
9
MA
58
3
MO
57
-3
NRG
59
-10
MSI
60
2
JNPR
59
3
F
35
-4
Financhill
Back

Cellectar Biosciences 10K Form

Sell
38

CLRB
Cellectar Biosciences

Last Price:
2.04
Seasonality Move:
-1.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-14.16M
Price / Cash Flow: 0
Annual Sales: $0.13
Price / Book: 18.15

Profitability

EPS (TTM): -3.09000
Net Income (TTM): $-53.53M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cellectar Biosciences Earnings Forecast

Key Cellectar Biosciences Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 15 years.

Cellectar Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
38
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?